Incyte Corporation
INCYFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
4,241
Cost of Revenue
378
Gross Profit
3,864
Gross Margin
91.1%
Operating Income
80
Operating Margin
1.9%
Net Income
33
Net Margin
0.8%
EPS (Basic)
$0.16
EPS (Diluted)
$0.15
EBITDA
408
EBITDA Margin
9.6%
2023
12/31/2023
Revenue
3,696
Cost of Revenue
315
Gross Profit
3,380
Gross Margin
91.5%
Operating Income
652
Operating Margin
17.6%
Net Income
598
Net Margin
16.2%
EPS (Basic)
$2.67
EPS (Diluted)
$2.65
EBITDA
919
EBITDA Margin
24.9%
2022
12/31/2022
Revenue
3,395
Cost of Revenue
253
Gross Profit
3,141
Gross Margin
92.5%
Operating Income
600
Operating Margin
17.7%
Net Income
341
Net Margin
10.0%
EPS (Basic)
$1.53
EPS (Diluted)
$1.52
EBITDA
600
EBITDA Margin
17.7%
2021
12/31/2021
Revenue
2,986
Cost of Revenue
187
Gross Profit
2,799
Gross Margin
93.7%
Operating Income
638
Operating Margin
21.3%
Net Income
949
Net Margin
31.8%
EPS (Basic)
$4.30
EPS (Diluted)
$4.27
EBITDA
630
EBITDA Margin
21.1%
2020
12/31/2020
Revenue
2,667
Cost of Revenue
162
Gross Profit
2,505
Gross Margin
93.9%
Operating Income
-240
Operating Margin
-9.0%
Net Income
-296
Net Margin
-11.1%
EPS (Basic)
$-1.36
EPS (Diluted)
$-1.36
EBITDA
-178
EBITDA Margin
-6.7%